Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 ...

Becton Dickinson (BDX) recently announced the initiation of a pharma-sponsored clinical trial featuring their BD Libertas Wearable Injector, alongside an affirmed quarterly dividend and leadership ...

Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...

Lab equipment maker Waters Corp on Monday said it will buy a bioscience and diagnostics unit spun off from medtech provider ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” second quarter 2025 investor ...

Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A ...

Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...

Key Takeaways Waters said it reached a deal to buy the Biosciences & Diagnostic Solutions business of Becton Dickinson for ...

This was the stock's second consecutive day of losses.

U.S. medical equipment supplier Becton Dickinson and Co (BDX.N) will acquire C R Bard Inc (BCR.N), in a $24 billion (£18.72 billion) cash-and-stock deal, adding Bard's devices to its portfolio in ...

Becton, Dickinson and Company (NYSE:BDX) is one of the stocks on Jim Cramer’s radar. Cramer mentioned the stock in light of ...

The El Paso Children's Hospital Foundation receives a $30,000 grant to support families with hospitalized children, covering non-medical needs.